TrialBMJ open2017

Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial.

James R Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.